Caremark Dismisses “Rationale” Behind Express Scripts’ Bid
This article was originally published in The Pink Sheet Daily
Pharmacy benefits manager says it will move forward with planned CVS merger.
You may also be interested in...
Firm urges shareholders to “send a message to the Caremark board and management” regarding its acquisition bid.
Express Scripts’ $26 billion hostile bid for Caremark represents a 15 percent premium over CVS’ offer.
A year in the making, the transaction could reshape the retail pharmacy landscape.